- Home
- LTRY vs SBFM Comparison
LTRY vs SBFM Comparison
Compare LTRY & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRY
- SBFM
- Stock Information
- Founded
- LTRY 2015
- SBFM 2006
- Country
- LTRY United States
- SBFM United States
- Employees
- LTRY N/A
- SBFM N/A
- Industry
- LTRY Computer Software: Prepackaged Software
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- LTRY Technology
- SBFM Health Care
- Exchange
- LTRY Nasdaq
- SBFM Nasdaq
- Market Cap
- LTRY N/A
- SBFM 7.7M
- IPO Year
- LTRY N/A
- SBFM N/A
- Fundamental
- Price
- LTRY $1.17
- SBFM $1.45
- Analyst Decision
- LTRY
- SBFM Strong Buy
- Analyst Count
- LTRY 0
- SBFM 1
- Target Price
- LTRY N/A
- SBFM $15.00
- AVG Volume (30 Days)
- LTRY 1.5M
- SBFM 84.3K
- Earning Date
- LTRY 08-18-2025
- SBFM 08-15-2025
- Dividend Yield
- LTRY N/A
- SBFM N/A
- EPS Growth
- LTRY N/A
- SBFM N/A
- EPS
- LTRY N/A
- SBFM N/A
- Revenue
- LTRY $1,030,318.00
- SBFM $36,234,578.00
- Revenue This Year
- LTRY N/A
- SBFM $192.48
- Revenue Next Year
- LTRY N/A
- SBFM N/A
- P/E Ratio
- LTRY N/A
- SBFM N/A
- Revenue Growth
- LTRY N/A
- SBFM 35.51
- 52 Week Low
- LTRY $0.22
- SBFM $1.17
- 52 Week High
- LTRY $2.65
- SBFM $8.78
- Technical
- Relative Strength Index (RSI)
- LTRY 46.72
- SBFM 48.48
- Support Level
- LTRY $1.04
- SBFM $1.41
- Resistance Level
- LTRY $1.39
- SBFM $1.58
- Average True Range (ATR)
- LTRY 0.12
- SBFM 0.12
- MACD
- LTRY -0.03
- SBFM -0.01
- Stochastic Oscillator
- LTRY 28.24
- SBFM 18.91
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.